주식 시장 뉴스
최신 금융 뉴스 · 업데이트 5월 24, 2026
Truist, Fifth Third Bancorp (FITB)의 PT를 하향 조정, Buy 등급 유지
Truist Lowers PT on Fifth Third Bancorp (FITB), Keeps a Buy Rating
The panel's net takeaway is that Truist's price target cut for FITB reflects concerns about slowing loan growth, net interest …
JD.com (JD)와 BYD가 전략적 파트너십 체결
JD.com (JD) and BYD Enters a Strategic Partnership
The panel views JD.com's partnership with BYD as a strategic move that leverages JD's logistics footprint and BYD's EV and …
Morgan Stanley는 Block (XYZ)에 대해 Buy 등급을 유지합니다.
Morgan Stanley Maintains a Buy on Block (XYZ)
The panel is largely bearish on Block (SQ), citing risks such as potential loss of institutional memory from significant headcount …
$2,000의 약물 상한은 현재 매년 1,500달러 이상으로 메디케어 퇴직자에게 절약
The $2,000 Drug Cap Is Saving Medicare Retirees Over $1,500 a Year Right Now
The $2,000 Part D cap provides significant relief for high-cost drug users but may have unintended consequences. While it increases …
Huntington Bancshares (HBAN) RBC 2026 컨퍼런스 발표, 알아두어야 할 점
Huntington Bancshares (HBAN) Presents at RBC 2026 Conference, Here’s What You Should Know
The panel's net takeaway is that HBAN's guidance is solid but faces significant risks, particularly around deposit betas, merger accounting, …
Stellantis (STLA) 고려 중인 중국 자동차 회사와의 파트너십
Stellantis (STLA) Considering Partnerships With Chinese Automakers
The panel consensus is that Stellantis' exploration of partnerships with Chinese OEMs is a desperate move to address its European …
미국 주식, 최악의 수준을 벗어나지만 여전히 하락세로 마감
U.S. Stocks Climb Well Off Worst Levels But Still Close Lower
The panelists agree that the market's resilience despite geopolitical tensions is deceptive, with energy infrastructure damage posing a significant risk …
배스터 주식의 실적이 다른 의료기기 주식과 비교했을 때 어떤가?
How Is Baxter's Stock Performance Compared to Other Medical Devices Stocks?
The panel consensus is bearish on Baxter (BAX), citing persistent margin pressure, operational struggles, and a high debt load. While …
G2 Investment Partners 새로운 포지션 Xometry 시작
G2 Investment Partners Initiates a New Position in Xometry
Despite impressive revenue growth, XMTR's significant net losses and unclear path to profitability remain a concern, with varying opinions on …
SBSW 주목할 만한 200일 이동평균선 하향 돌파
SBSW Makes Notable Cross Below Critical Moving Average
The panel consensus is bearish on Sibanye Stillwater (SBSW) due to its sensitivity to PGM prices, South African operational risks, …
바이오마린 제약(BMRN)이 VOXZOGO의 진행 중인 임상 시험에서 긍정적인 결과를 발표
BioMarin Pharmaceutical (BMRN) Reports Positive Results From Ongoing Trials of VOXZOGO
The panel discusses BioMarin's VOXZOGO (vosoritide) data, with mixed views on its commercial potential. Bulls highlight label expansion to infants …
그리스의 새로운 방공 계획, 록히드 마틴 주식에 도움이 될까요?
Will Greece's New Air Defense Plan Boost Lockheed Martin's Stock?
The panel generally agrees that the $36B Greece deal for Lockheed Martin (LMT) is geopolitically important but economically modest, with …